ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.
- DOI
- 10.1038/s41416-026-03413-1
- Published
- 2026 Jul
- Container
- British journal of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-026-03413-1,
title = {ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.},
author = {Xie X and Lee J and Gi YJ and Poullikkas T and Fuson JA and Fan PD and Fukui JA and Tripathy D and Ueno NT},
year = {2026},
journal = {British journal of cancer},
doi = {10.1038/s41416-026-03413-1},
url = {https://doi.org/10.1038/s41416-026-03413-1}
}RIS
TY - JOUR TI - ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage. AU - Xie X AU - Lee J AU - Gi YJ AU - Poullikkas T AU - Fuson JA AU - Fan PD AU - Fukui JA AU - Tripathy D AU - Ueno NT PY - 2026 JO - British journal of cancer DO - 10.1038/s41416-026-03413-1 UR - https://doi.org/10.1038/s41416-026-03413-1 ER -
APA
X, X., J, L., YJ, G., T, P., JA, F., PD, F., JA, F., D, T., & NT, U. (2026). ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.. British journal of cancer. https://doi.org/10.1038/s41416-026-03413-1
Source records
- pubmed · retrieved 2026-09-26T18:01:44.749Z